Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy.
Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy. Cancer Discov. 2018 11; 8(11):1376-1389.
View in:
PubMed
subject areas
Animals
Antibiotics, Antineoplastic
Daunorubicin
Drug Resistance, Neoplasm
Humans
Leukemia, Myeloid, Acute
Mice
Mice, Inbred NOD
Mice, SCID
Polycomb Repressive Complex 2
Proto-Oncogene Proteins c-mdm2
Tumor Cells, Cultured
Tumor Suppressor Protein p53
Xenograft Model Antitumor Assays
authors with profiles
Alexander J. Ruthenburg